Full View

Emerging therapeutic biomarkers in endometrial cancer

P Dong, M Kaneuchi, Y Konno, H Watari… - BioMed research …, 2013 - Wiley Online Library
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …
被引用次数：69 相关文章
[PDF] researchgate.net

[PDF][PDF] Emerging Therapeutic Biomarkers in Endometrial Cancer

P Dong, M Kaneuchi, Y Konno, H Watari, S Sudo… - 2013 - researchgate.net
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …

Emerging Therapeutic Biomarkers in Endometrial Cancer

P Dong, M Kaneuchi, Y Konno… - BioMed Research …, 2013 - eprints.lib.hokudai.ac.jp
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …

Emerging Therapeutic Biomarkers in Endometrial Cancer

P Dong, M Kaneuchi, Y Konno, H Watari… - BioMed Research …, 2013 - search.proquest.com
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …

Emerging therapeutic biomarkers in endometrial cancer

P Dong, M Kaneuchi, Y Konno, H Watari… - BioMed Research …, 2013 - go.gale.com
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …

Emerging Therapeutic Biomarkers in Endometrial Cancer

P Dong, M Kaneuchi, Y Konno, H Watari… - BioMed Research …, 2013 - cir.nii.ac.jp
抄録< jats: p> Although clinical trials of molecular therapies targeting critical biomarkers
(mTOR, epidermal growth factor receptor/epidermal growth factor receptor 2, and vascular …

Emerging therapeutic biomarkers in endometrial cancer

P Dong, M Kaneuchi, Y Konno… - BioMed research …, 2013 - pubmed.ncbi.nlm.nih.gov
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …
[PDF] core.ac.uk

[PDF][PDF] Emerging Therapeutic Biomarkers in Endometrial Cancer

P Dong, M Kaneuchi, Y Konno, H Watari, S Sudo… - 2013 - core.ac.uk
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …
[HTML] nih.gov

[HTML][HTML] Emerging Therapeutic Biomarkers in Endometrial Cancer

P Dong, M Kaneuchi, Y Konno, H Watari… - BioMed Research …, 2013 - ncbi.nlm.nih.gov
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …
[PDF] researchmap.jp

[PDF][PDF] Emerging Therapeutic Biomarkers in Endometrial Cancer

P Dong, M Kaneuchi, Y Konno, H Watari, S Sudo… - 2013 - researchmap.jp
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal
growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth …